Sun Pharmaceutical Industries has informed that Sun Pharmaceutical Industries (together with its subsidiaries and/or affiliates referred to as Sun Pharma), has entered into an agreement, pursuant to which Sun Pharma, through its wholly owned subsidiary, has agreed to acquire 100% shares of Valstar S.A. (Valstar). Further, Kemipharm S.A. (Kemipharm) is a subsidiary of Valstar and as a result of acquisition of Valstar and other minority shareholders, Sun Pharma would acquire entire stake in Kemipharm. The particulars of the disclosure required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III are provided in Annexure A, enclosed.
The above information is a part of company’s filings submitted to BSE.